Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury
Qianxue Mou,Ke Yao,Meng Ye,Bowen Zhao,Yuanyuan Hu,Xiaotong Lou,Huixia Li,Hong Zhang,Yin Zhao
DOI: https://doi.org/10.2147/JIR.S338815
IF: 4.5
2021-12-14
Journal of Inflammation Research
Abstract:Qianxue Mou, 1 Ke Yao, 1 Meng Ye, 1 Bowen Zhao, 1 Yuanyuan Hu, 1 Xiaotong Lou, 1 Huixia Li, 2 Hong Zhang, 1 Yin Zhao 1 1 Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2 Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China Correspondence: Hong Zhang Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Correspondence: Yin Zhao Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Purpose: Optic nerve injury (ONI) causes neuroinflammation and neurodegeneration leading to visual deficits. The response of microglia has emerged as an impactful component of etiology in neurodegeneration. This study aimed to investigate the effect of SIRT1-mTORC1 signaling pathway in microglia regulation after ONI. Methods: Cx3Cr1-Cre ERT2 / Raptor F/F and Cx3Cr1-Cre ERT2 / Sirt1 F/F mice were used to delete Raptor and Sirt1 in microglia, respectively. Optic nerve crush (ONC) model was established to mimic ONI. PLX5622, a highly specific inhibitor of the colony-stimulating factor 1 receptor (CSF1R), is used to eliminate microglia in optic nerve. Ionized calcium binding adaptor molecule 1 (Iba1) immunostaining was used to detect microglial activation. Retinal ganglion cells (RGCs) were quantified by Nissl staining and retinal whole-mount immunostaining with RNA-binding protein with multiple splicing (RBPMS). Axonal damage was valued by transmission electron microscopy (TEM). Results: Microglial activation emerged on day 3 post ONC and was earlier than RGCs loss which occurred at day 5 after injury. Depleting microglia with PLX5622 could attenuate the loss of RGCs and axon damage after ONC. Gain- and loss-of-function studies revealed that SIRT1 determined the activation of microglia in optic nerve. In addition, microglia-specific deletion of Raptor resulted in decreased microglial activation. Interestingly, activating mTORC1 with CCT007093 could reverse the function of SIRT1 in regulating the process of microglial activation mediated RGCs loss. Conclusion: Our study reveals a potential novel mechanism of SIRT1-mTORC1 pathway in microglia regulation, and indicates a therapeutic potential for the protection of RGCs in ONI. Keywords: microglia, retinal ganglion cells, optic nerve injury, SIRT1, mTORC1 Diverse pathological states cause degeneration of axons leading to irreversible vision loss, including ocular hypertension, trauma and optic neuritis. 1,2 In these relative diseases, focal axon injury triggers a propagating axon loss and eventually neuronal death. 3 Therefore, axonal injury is thought to be the critical early event for RGCs loss. Multiple glial cell types participate in the process of axonal degeneration after optic nerve injury (ONI), including oligodendroglia, astroglia and microglia. 4–6 The microglia form a population of resident macrophages within the retina and optic nerve. 6,7 In healthy retina, microglia are of vital importance in maintain the normal structure and functioning of the retina. 8 Once activated by noxious insults, microglia can release inflammatory cytokines, such as TNF-α, IL-1β and reactive oxygen species, which could damage RGCs and promote neurodegeneration, and inappropriate phagocytosis by microglia can further accelerate RGCs loss. 9,10 A previous study has shown that microglial activation can aggravate trauma-induced RGCs degeneration, which leads to RGCs loss. 11 Thus, regulation of microglial activation enables microglia to function better as guardians during pathological processes. 12 Besides immune activity, the microglia also participate in the development and maintenance of neural networks, as well as in neurovascular unit homeostasis. 7,13,14 Noteworthy, genetic ablation and/or pharmacological blockade of microglia shows neuroprotective effect in neurodegenerative diseases. 15,16 Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, deacetylates transcription factors, signaling molecules, and histones. 17,18 Resveratrol enhances SIRT1 activity via promoting NADH oxidation to NAD+ and, possibly, by boosting SI -Abstract Truncated-
immunology